General form of registration statement for all companies including face-amount certificate companies

Consolidated Balance Sheets (Parentheticals)

v3.24.4
Consolidated Balance Sheets (Parentheticals) - $ / shares
Sep. 30, 2024
Dec. 31, 2023
Dec. 31, 2022
Preferred Stock, Shares Authorized (in shares) 20,655,895 20,655,895  
Common Stock, Par Value (in dollars per share) $ 0.00001 $ 0.00001 $ 0.00001
Common Stock, Shares Authorized (in shares) 29,000,000 29,000,000 29,000,000
Common Stock, Shares Issued (in shares) 5,720,009 5,720,009 5,720,009
Common Stock, Shares Outstanding (in shares) 5,720,009 5,720,009 5,720,009
Pieris Pharmaceuticals, Inc. [Member]      
Preferred Stock, Par Value (in dollars per share) $ 0.001 $ 0.001 $ 0.001
Preferred Stock, Shares Authorized (in shares) 10,000,000 10,000,000 10,000,000
Preferred Stock, Shares Issued (in shares) 15,618 15,617 15,617
Preferred Stock, Shares Outstanding (in shares) 15,618 15,617 15,617
Common Stock, Par Value (in dollars per share) $ 0.001 $ 0.001 $ 0.001
Common Stock, Shares Authorized (in shares) 3,750,000 3,750,000 3,750,000
Common Stock, Shares Issued (in shares) 1,320,240 1,236,688 931,489
Common Stock, Shares Outstanding (in shares) 1,320,240 1,236,688 931,489